Jump to section
Ganymede is building the first PaaS for biotech software engineering and integration, with a mission of improving the world through better healthcare outcomes and medicine.
182% employee growth in 12 months
Ganymede bills itself as the world’s first Platform-as-a-Service (PaaS), for biotech software engineering, allowing scientists to quickly import data, connect and integrate apps and instruments, and automate their lab on one platform.
Though it's still very early days for the company, the fact that its built an original product gives it an obvious edge. Further encouragement comes in the name of its main early investor BoxGroup, an early-stage specialist which has backed high-growth companies such as Trello, Airtable, and Bowery Farms in their infancy.
That Ganymede’s co-founder Nathan Clark was a Product Manager at Benchling, a renowned startup platform for biotechnology R&D is also a good sign that the company can scale quickly over the next few years.
Kirsty
Company Specialist at Welcome to the Jungle
Dec 2022
$12.8m
SERIES A
Mar 2022
$2.9m
SEED
This company has top investors
Nathan Clark
(Co-founder & CEO)Former Goldman Sachs Trader. Pivoted to Product Management, serving in the role at Fintech company Affirm.inc, then at Benchling - a cloud-based platform for biotechnology research and development.
Benson Lee
(Co-founder)Spent over eleven years at Citigroup in a variety of roles, including VP of Consumer Finance & Global Securitized Markets. Before co-founding Ganymede, worked for Fintech company Affirm.inc as Senior Director & Head of Quantitative Markets.